Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection

Experimental Parasitology

Volumn 121, Issue 1, 2009, Pages 8-14

  Santos, Daniela Maria dos ^a   Talvani, André ^a   da Mata Guedes, Paulo Marcos ^a   Machado Coelho, George Luiz Lins ^a   de Lana, Marta ^a   Bahia, Maria Terezinha ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Benznidazole (BZ); Genetic diversity; Genotypes; Immunoglobulin G (IgG); Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; GENETIC LINKAGE; GENETIC VARIABILITY; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SEROLOGY; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VARIATION; GENOTYPE; IMMUNOGLOBULIN G; MICE; NITROIMIDAZOLES; PHYLOGENY; RANDOM ALLOCATION; TIME FACTORS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 57049132738     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.09.012     Document Type: Article

References (43)

1. Anonymous. Recommendations from a satellite meeting. Memórias do Instituto Oswaldo Cruz 94 (1999) 429-432
2. Barnabé C., Brisse S., and Tibayrenc M. Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach. Parasitology 120 (2000) 513-526
3. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. International Archives of Allergy and Immunology 114 (1997) 103-110
4. Brenière S.F., Carrasco R., Revollo S., Aparicio G., Desjeux P., and Tibayrenc M. Chagaś disease in Bolívia: clinical and epidemiological features and zymodeme variability of Trypanosoma cruzi strains isolated from patients. American Journal of Tropical Medicine and Hygiene 41 (1989) 521-529
5. Castro A.M., Luquetti A.O., Rassi A., Rossi G.G., Chiari E., and Galvão L.M. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitology Research 88 (2002) 894-900
6. Cerban F.M., Gea S., Menso E., and Voteero-Cima E. Chagaś disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clinical Immunology and Immunopathology 67 (1993) 25-30
7. Colégio Brasileiro de Experimentação Animal, 2006. Legislação e ética. Available at: http://www.cobea.org.br/. Accessed on March 2008.
8. Cordeiro F.D., Martins-Filho O.A., Costa Rocha M.O., Adad S.J., Corrêa-Oliveira R., and Romanha A.J. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas disease. Clinical and Diagnostic Laboratory Immunology 8 (2001) 112-118
9. de Diego J.A., Palau M.T., Gamallo C., and Penin P. Relationships between histopathological findings and phylogenetic divergence in Trypanosoma cruzi. Tropical Medicine and International Health 3 (1998) 222-233
10. Dias J.C.P., Silveira A.C., and Schofield C.J. The impact of Chagas disease control in Latin America. Memórias do Instituto Oswaldo Cruz 97 (2002) 603-612
11. Elias F.E., Vigliano C.A., Laguens R.P., Levin M.J., and Berec C. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease. American Journal of Tropical Medicine and Hygiene 46 (2003) 242-247
12. Escobar A.L., Fernandez-Gomez R., Peter J.C., Mobini R., Hoebeke J., and Mijares A. IgGs and Mabs against the beta2-adrenoreceptor block A-V conduction in mouse hearts: A possible role in the pathogenesis of ventricular arrhythmias. Journal of Molecular and Cellular Cardiology 40 (2006) 829-837
13. Fernandes O., Souto R.P., Castro J.A., Pereira J.B., Fernandes N.C., Junqueira A.C., Naiff R.D., Barret T.B., Degrave W., Zingales B., Campbell D.A., and Coura J.R. Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exons and ribosomal RNA sequence. American Journal of Tropical Medicine and Hygiene 58 (1998) 807-811
14. Ferreira A.W., and de Avila S.D. Laboratory diagnosis of Chagas' heart disease. Revista Paulista de Medicina 113 (1995) 767-771
15. Filardi L.S., and Brener Z. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81 (1987) 755-759
16. Giordanengo L., Maldonado C., Rivarola H.W., Iosa D., Girones N., Fresno M., and Gea S. Induction of antibodies reactive to cardiac myosin and development of heart alterations in cruzipain-immunized mice and their offspring. European Journal of Immunology 30 (2000) 3181-3189
17. Gomes M.L., Galvão L.M., Macedo A.M., Pena S.D., and Chiari E. Chagas' disease diagnosis: comparative analysis of parasitologic, molecular and serologic methods. American Journal of Tropical Medicine and Hygiene 60 (1999) 205-210
18. Gomes Y.M., Pereira V.R., Nakazawa M., Rosa D.S., Barros M.D., Ferreira A.G., Silva E.D., Ogatta S.F., Krieger M.A., and Goldenberg S. Serodiagnosis of chronic Chagas infection by using EIE-recombinant Chagas-Biomanguinhos kit. Memórias do Instituto Oswaldo Cruz 96 (2001) 497-501
19. Guedes P.M.M., Veloso V.M.V., Tafuri W.L., Galvão L.M., Carneiro C.M., Lana M., Chiari E., Ataide-Soares K., and Bahia M.T. The dog as a model for chemotherapy of the Chagas' disease. Acta Tropica 84 (2002) 9-17
20. Guedes P.M., Veloso V.M., Gollob K.J., Afonso L.C., Caldas I.S., Vianna P., de Lana M., Chiari E., Bahia M.T., and Galvão L.M. IgG isotype profile is correlated with cardiomegaly in Beagle dogs infected with distinct Trypanosoma cruzi strains. Veterinary Immunology and Immunopathology 124 (2008) 163-168
21. Hernández-Becerril N., Nava A., Reyes P.A., and Monteon V.M. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Archivos de Cardiologia de Mexico 71 (2001) 199-205
22. Jones E.M., Colley D.G., Tostes S.J., Lopes E.R., Vnencak-Jones C.L., and MacCurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from human inflammatory lesions in human chagasic cardiomyopathy. American Journal of Tropical Medicine and Hygiene 41 (1993) 348-357
23. Malan A.K., Avelar E., Litwin S.E., and Hill H.R. Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. Journal of Medical Microbiology 55 (2006) 171-178
24. Marcon G.E., Andrade P.D., de Albuquerque D.M., Wanderley J.S., de Almeida E.A., Guariento M.E., and Costa S.C. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagnostic Microbiology and Infectious Disease 43 (2002) 39-43
25. Mejia A.M., and Triana O. Genetic variability of Trypanosoma cruzi in blood and organs of infected mice determined by LSSP-PCR. Biomedica 25 (2005) 76-86
26. Michailowsky V., Luhrs K., Rocha M.O., Fouts D., Gazzinelli R.T., and Manning J.E. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas's disease. Infection and Immunity 71 (2003) 3165-3171
27. Ministério da Saúde, 1998. Normas técnicas para coleta, processamento e transfusão de sangue, componentes e derivados. Portaria no. 721, Diário Oficial da União, Brasília.
28. Morgan J., Dias J.C., Gontijo E.D., Bahia-Oliveira L., Correa-Oliveira R., Colley D.G., and Powell M.R. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different manifestations of Chagas disease. American Journal of Tropical Medicine and Hygiene 55 (1996) 355-559
29. Myamoto C.T., Gomes M.L., Marangon A.V., Araújo S.M., Bahia M.T., Lana M., and Toledo M.J.O. Trypanosoma cruzi: sensitivity of the polymerase chain reaction for detecting the parasite in the blood of mice infected with different clonal genotypes. Experimental Parasitology 112 (2006) 198-201
30. Ostermayer A.L., and Castro A.M. Diagnóstico sorológico da doença de Chagas. In: Dias J.C., and Coura J.R. (Eds). Clínica e Terapêutica da Doença de Chagas (1997), Editora Fiocruz, Rio de Janeiro
31. Revelli S., Le Page C., Piaggio E., Wietzerbin J., and Botasso O. Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clinical and Experimental Immunology 118 (1999) 271-277
32. Rocha M.O., Teixeira M.M., and Ribeiro A.L. An update on the management of Chagas cardiomyopathy. Expert Review of Anti-Infective Therapy 5 (2007) 727-743
33. Rowland E.C., Mikhail K.S., and McCormick T.S. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagás disease. Journal of Parasitology 78 (1992) 557-561
34. Spinella S., Liegeard P., and Hontebeyrie-Joskowicz M. Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas's disease. Experimental Parasitology 74 (1992) 46-56
35. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends in Parasitology 18 (2002) 262-263
36. Tibayrenc M., Ward P., Moya A., and Ayala F.J. Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proceedings of the National Academy of Sciences of the USA 83 (1986) 115-119
37. Tibayrenc M., Neubauer K., Barnabé C., Guenine F., Skarecky D., and Ayala F.J. Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis. Proceedings of the National Academy of Sciences 90 (1993) 1335-1339
38. Toledo M.J.O., Lana M., Carneiro C.M., Bahia M.T., Machado-Coelho G.L., Veloso V.M., Barnabé C., Tibayrenc M., and Tafuri W.L. Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Experimental Parasitology 100 (2002) 61-172
39. Toledo M.J., Bahia M.T., Carneiro C.M., Martins-Filho O.A., Tibayrenc M., Barnabé C., Tafuri W.L., and de Lana M. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy 47 (2003) 223-230
40. Volter A., Bidwell D.E., and Bartlett A. Enzyme immunoassays in diagnostic medicine - theory and practice. Bulletin of the Word Health Organization 53 (1976) 55-65
41. World Health Organization, 1991. Control of Chagas Disease. WHO Technical Report Series 81:38-47.
42. World Health Organization, 2005. Tropical Disease Research: progress 2003-2004 Seventeenth Programme Report of the UNICEF/UNDP/World Bank/WHO. Special Programme for Research and Training in Tropical Diseases. Programme Report no. 17.
43. Zauza P.L., and Borges-Pereira J. Sera levels of anti-Trypanosoma cruzi IgG in the course of chagasic cardiopathy in 10 years. Revista da Sociedade Brasileira de Medicina Tropical 34 (2001) 399-405